Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Abdul Mannan: Managing Bleeding in Acquired Haemophilia A – Choosing the Right Haemostatic Strategy
Abdul Mannan/LinkedIn
May 30, 2026, 14:52

Abdul Mannan: Managing Bleeding in Acquired Haemophilia A – Choosing the Right Haemostatic Strategy

Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:

“In acquired haemophilia A, the best haemostatic agent depends on the patient in front of you.

Acquired haemophilia A is not the moment to admire a prolonged APTT from a distance.

If the patient is bleeding, act early and involve a haemophilia centre.

The new BSH/UKHCDO guideline keeps the message practical:

  • Control bleeding first
  • Avoid trauma and procedures where possible
  • Use rFVIIa, aPCC/FEIBA, or rpFVIII for bleeding patients
  • Monitor bypassing agents clinically, not by routine clotting tests
  • Use rpFVIII when FVIII measurement can guide treatment
  •  Start inhibitor eradication with immunosuppression, tailored to risk

The key point?

BSH does not crown one universal winner between FEIBA, rFVIIa, and rpFVIII.

The right choice depends on the bleed, thrombotic risk, anti-porcine FVIII inhibitor status, lab support, access, and local haemophilia centre practice.

FEIBA/aPCC and rFVIIa remain trusted bypassing options. rpFVIII has the practical advantage of measurable FVIII levels, which can be very helpful when the bleeding is severe or the response is unclear.

AHA is rare, but when it appears, it tends to theatre. The platelet count sits there innocently while the APTT does all the shouting.

What drives your first choice in AHA bleeding: thrombosis risk, lab monitoring, local access, or centre protocol?”

Abdul Mannan: Managing Bleeding in Acquired Haemophilia A - Choosing the Right Haemostatic Strategy

Find more posts from Abdul Mannan on Hemostasis Today.

Abdul Mannan bleeding disorders Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Medicine thrombosis WFH
NewsFeed